Skip to Content
U.S. National Institutes of Health

Exploratory Studies in Cancer Detection, Diagnosis and Prognosis

Program Announcement: PA-03-003

(Replaces PA-03-003, Exploratory Studies in Cancer Detection, Prognosis and Prediction)

Full Announcement with Application Instructions:
http://grants.nih.gov/grants/guide/pa-files/PA-05-165.html

Application Receipt Dates: February 1, June 1, October 1, 2006; February 1, June 1, October 1, 2007; February 1, June 1, October 1, 2008
Expires: November 2, 2008

The Division of Cancer Treatment and Diagnosis and the Division of Cancer Prevention of the National Cancer Institute invite research grant applications from interested investigators to explore innovative strategies for the early detection of cancer, assessment of cancer prognosis or prediction of response to cancer treatment. Advances in the understanding of basic cancer biology and the development of powerful molecular technologies are leading to the identification of many new abnormalities in precancerous and cancer cells. This initiative promotes the initial evaluation of molecular or cellular characteristics in human specimens and/or the development of assays that may result in important advances in the detection, diagnosis and treatment of cancers.

The objective of this Program Announcement is to encourage applications for exploratory (R21) grants from individuals who are interested in testing new ideas that are based on a sound scientific rationale and may advance progress in cancer detection and diagnosis. The R21 grant mechanism is utilized to support pilot projects or feasibility studies that may produce innovative advances in science.

Contact(s):
Dr. James V. Tricoli
Phone: 301-496-1591
Email: tricolij@mail.nih.gov

Dr. Heng Xie
Phone: 301-496-8866
E-mail: xieh@ctep.nci.nih.gov

Dr. Sudhir Srivastava
Phone: 301-435-1594
E-mail: SS1A@nih.gov